Send to

Choose Destination
See comment in PubMed Commons below
Ann Clin Lab Sci. 1983 Mar-Apr;13(2):137-42.

Lipid-bound sialic acid as a tumor marker.


Significant elevations in plasma/serum lipid bound sialic acid (LSA) concentrations have been documented in patients with malignant diseases. Initial studies indicate that LSA may be a useful marker in cancer of the prostate, bladder, breast, lung, colon, ovary and in leukemia, lymphoma, Hodgkins disease and melanoma. The data suggest that the LSA test lacks the required sensitivity and specificity for routine cancer detection but may be a valuable adjunct in the clinical evaluation of the cancer patient.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center